NanoViricides
NNVC
NZ$2.28
Share price
-0.72%
Change (1 day)
-20.26%
Change (1 year)
Categories
NanoViricides (NNVC) - Total debt
Total debt on the balance sheet as of September 2023 : NZ$2.47 Million
According to NanoViricides's latest financial reports the company's total debt is NZ$2.47 Million. A company’s total debt is the sum of all current and non-current debts.
NanoViricides - Total debt on balance sheet (from 2006 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-06-30 | NZ$0.15 M | 11.51% |
| 2021-06-30 | NZ$0.13 M | -92.32% |
| 2020-06-30 | NZ$1.77 M | |
| 2017-06-30 | NZ$5.4 M | -55.2% |
| 2016-06-30 | NZ$12.06 M | 14.01% |
| 2015-06-30 | NZ$10.58 M | 129.63% |
| 2014-06-30 | NZ$4.6 M | 2.8% |
| 2013-06-30 | NZ$4.48 M | |
| 2006-06-30 | NZ$1.51 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 BioCryst Pharmaceuticals
BCRX | NZ$1.31 B | 52,899.00% | 🇺🇸 USA |
 Novavax NVAX | NZ$0.37 B | 15,143.93% | 🇺🇸 USA |
 Gilead Sciences GILD | NZ$41.13 B | 1,663,366.67% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | NZ$84.47 B | 3,415,833.33% | 🇺🇸 USA |
 Merck MRK | NZ$57.44 B | 2,322,833.33% | 🇺🇸 USA |
 GlaxoSmithKline GSK | NZ$39.26 B | 1,587,620.00% | 🇬🇧 UK |